CYBIN INC.
A late-stage neuropsychiatry company developing psychedelic-based therapeutics.
CYBN | US
Overview
Corporate Details
- ISIN(s):
- CA23256X1006
- LEI:
- Country:
- United States of America
- Address:
- 100 KING STREET WEST, TORONTO
- Website:
- https://www.cybin.com
- Sector:
- Manufacturing
Description
Cybin Inc. is a late-stage clinical neuropsychiatry company dedicated to revolutionizing mental healthcare by developing novel psychedelic-based therapeutics. The company utilizes proprietary drug discovery platforms, innovative drug delivery systems, and a deuterated chemical process to engineer next-generation, patent-protected drug candidates from tryptamine-based scaffolds. Its lead programs include CYB003, a deuterated psilocybin analog for Major Depressive Disorder (MDD) that has received FDA Breakthrough Therapy Designation, and CYB004 for the treatment of Generalized Anxiety Disorder (GAD). Cybin aims to create safer, more effective, and commercially scalable treatments for various mental health conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CYBIN INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CYBIN INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CYBIN INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
